{"id":106301,"date":"2023-10-01T04:46:02","date_gmt":"2023-10-01T04:46:02","guid":{"rendered":"https:\/\/dailytalks.org\/?p=106301"},"modified":"2023-10-01T04:46:02","modified_gmt":"2023-10-01T04:46:02","slug":"immunovant-shares-surge-after-antibody-treatment-succeeds-in-early-stage-study","status":"publish","type":"post","link":"https:\/\/dailytalks.org\/?p=106301","title":{"rendered":"Immunovant shares surge after antibody treatment succeeds in early-stage study"},"content":{"rendered":"<p>Shares of Immunovant <a target=\"_blank\" rel=\"noopener\">https:\/\/www.reuters.com\/markets\/companies\/IMVT.O&#8221;<\/a> target=&#8221;_blank&#8221; rel=&#8221;noopener&#8221;>(IMVT.O)<\/a> more than doubled on Tuesday after early-stage data from its experimental antibody treatment exceeded analysts&#8217; expectations.<br \/><a href=\"https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/immunovant-shares-surge-after-antibody-treatment-succeeds-early-stage-study-2023-09-26\/\" class=\"button purchase\" rel=\"nofollow noopener\" target=\"_blank\">Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Shares of Immunovant https:\/\/www.reuters.com\/markets\/companies\/IMVT.O&#8221; target=&#8221;_blank&#8221; rel=&#8221;noopener&#8221;>(IMVT.O) more than doubled on Tuesday after early-stage data from<\/p>\n","protected":false},"author":1,"featured_media":106302,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26],"tags":[],"class_list":["post-106301","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-lse-mrkt"],"featured_image_urls":{"full":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/106301-immunovant-shares-surge-after-antibody-treatment-succeeds-in-early-stage-study.webp",1200,628,false],"thumbnail":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/106301-immunovant-shares-surge-after-antibody-treatment-succeeds-in-early-stage-study-150x150.webp",150,150,true],"medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/106301-immunovant-shares-surge-after-antibody-treatment-succeeds-in-early-stage-study-300x157.webp",300,157,true],"medium_large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/106301-immunovant-shares-surge-after-antibody-treatment-succeeds-in-early-stage-study-768x402.webp",640,335,true],"large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/106301-immunovant-shares-surge-after-antibody-treatment-succeeds-in-early-stage-study-1024x536.webp",640,335,true],"1536x1536":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/106301-immunovant-shares-surge-after-antibody-treatment-succeeds-in-early-stage-study.webp",1200,628,false],"2048x2048":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/106301-immunovant-shares-surge-after-antibody-treatment-succeeds-in-early-stage-study.webp",1200,628,false],"chromenews-featured":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/106301-immunovant-shares-surge-after-antibody-treatment-succeeds-in-early-stage-study-1024x536.webp",1024,536,true],"chromenews-large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/106301-immunovant-shares-surge-after-antibody-treatment-succeeds-in-early-stage-study-825x575.webp",825,575,true],"chromenews-medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/106301-immunovant-shares-surge-after-antibody-treatment-succeeds-in-early-stage-study-590x410.webp",590,410,true]},"author_info":{"display_name":"Jonathan Jeriah","author_link":"https:\/\/dailytalks.org\/?author=1"},"category_info":"<a href=\"https:\/\/dailytalks.org\/?cat=26\" rel=\"category\">London Market<\/a>","tag_info":"London Market","comment_count":"0","_links":{"self":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/106301","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=106301"}],"version-history":[{"count":0,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/106301\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/media\/106302"}],"wp:attachment":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=106301"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=106301"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=106301"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}